Streptococcal Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
[Report Updated: 30-05-2017]

Published by Delve Insight: 30 May 2017 | 86313

Sorry, this report is no longer available.

We may have other suitable reports available - try Searching for Streptococcal
or contact our sales team for personal assistance: phone +44 (0)7887945155 or email pdb@bioportfolio.co.uk.

Introduction

DelveInsight’s Report, “Streptococcal Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Streptococcal Infections Report is to understand the market and pipeline status of the drugs around the Streptococcal Infections to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight’s Report provides the historical and forecasted sales of the drugs till 2018. The Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Streptococcal Infections. While the leading brands, companies and chemicals are considered thoroughly, DelveInsight’s report also provides details on the Global API Manufacturers across the globe covering Drug Master Filings of US, Europe and API Manufacturers in Asia specifically China and India.

Please note:This report requires certain updates. We have all the information available but require 48-72 Hours to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

SCOPE:

• A snapshot of the global Market and Phase III therapeutics scenario for Streptococcal Infections.

• A review of the marketed products under prescription for Streptococcal Infections, regulatory information and marketing status.

• Coverage of global patent coverage and detailed commentaries on the US patent challenges.

• Graphical representation of investigational products for patent expiry and market exclusivities across the globe.

• Product profiles for marketed products for Streptococcal Infections with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details.

• Coverage of API Manufacturers for Streptococcal Infections drugs in the United States, Europe and Asian Regions with location details.

• Coverage of Regulatory filings in theUS, Europe, and Asia specifically India and China for Streptococcal Infections drugs.

• Coverage of Route of Synthesis of Active Pharmaceutical Ingredient associated with Streptococcal Infections drugs.

• Coverage of Streptococcal Infections Phase III pipeline products featuring sections on product description, mechanism of action, Chemical details and research & development progress.

• Coverage of the United States Drug Master File (US DMF) available for Phase III Pipeline Drugs.

• Key discontinued Marketed products.

• Global Sales Figure to 2018.

Reasons to buy

• Evaluate the marketing status and exclusivity details of Streptococcal Infections key products to exploit opportunities for generic drug development opportunities.

• Identify and understand important and diverse types of therapeutics under Phase III development for Streptococcal Infections.

• Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Streptococcal Infections.

• API intelligence over marketed drugs forStreptococcal Infectionsand gaining primary intelligence over active ingredients manufacturers across the globe.

• API intelligence over leading Phase III Pipeline drugs.

• Develop and designstrategies by identifying the API manufacturers for Phase III Pipeline products to enhance and expand business potential and scope.

• Understanding the scope of the Phase III Drugs with nil regulatory filings.

• Understanding the chemical route of synthesis of approved drugs for Streptococcal Infections.

• Uncovering opportunities in the rapidly growing US market.

Table of Contents
for Streptococcal Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017 [Report Updated: 30-05-2017]

List Of Tables
in Streptococcal Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017 [Report Updated: 30-05-2017]

• Streptococcal Infections Therapeutic Market, US, Marketed Drugs by Application Type, 2017

• Streptococcal Infections Therapeutic Market, US, Marketed Drugs by Marketing Status, 2017

• Streptococcal Infections Therapeutic Market, US, (Year), 2017

• Streptococcal Infections Marketed Drugs, API Manufacturers by US DMF Status, 2017

• Streptococcal Infections Marketed Drugs, US DMF Status Drug Specific (Number), 2017

• Streptococcal Infections Drugs, API Manufacturers, Europe by Country, 2017

• Streptococcal Infections Drugs, API Manufacturers, India by State, 2017

• Streptococcal Infections Drugs, API Manufacturers, China by Province, 2017

• Streptococcal Infections Drugs, API Manufacturers by Geography 2017

• Streptococcal Infections Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2017

• Streptococcal Infections Therapeutic Market, Global Sales-2018 (in million USD)

• API Manufacturers for Drug, 2017

• Phase III Drugs for Streptococcal Infections, 2017

• Discontinued Drugs for Streptococcal Infections, 2017

List Of Figures, Charts and Diagrams
in Streptococcal Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017 [Report Updated: 30-05-2017]

• Streptococcal Infections Therapeutic Market, US, Marketed Drugs by Application Type (%), 2017

• Streptococcal Infections Therapeutic Market, US, Marketed Drugs by Marketing Status (%), 2017

• Streptococcal Infections Therapeutic Market, US, (Year), 2017

• Streptococcal Infections Marketed Drugs, API Manufacturers by US DMF Status (%), 2017

• Streptococcal Infections Marketed Drugs, US DMF Status Drug Specific (Number), 2017

• Streptococcal Infections Drugs, API Manufacturers, Europe by Country, 2017

• Streptococcal Infections Drugs, API Manufacturers, India by State, 2017

• Streptococcal Infections Drugs, API Manufacturers, China by Province, 2017

• Streptococcal Infections Drugs, API Manufacturers by Geography 2017

• Streptococcal Infections Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2017

• Streptococcal Infections Therapeutic Market, Global Sales 2018 (in million USD)

• Drug, Patent/Exclusivity Expiry (Year), 2017

Additional Details

Publisher

Delve Insight

Publisher Information

DelveInsight is a leading Business Consulting and Market Research Firm. We combine industry expertise with probing market insights in innovative ways to deliver enduring results to deliver critical information to leading decision makers.



We help our clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. DelveInsight is a knowledge partner for business strategy and market research across the drug value chain.

Reference

86313 | DIIR2017147

Number of Pages

100

Report Format

PDF

Delve Insight Reports

Related Reports

TitleDate PublishedPrice fromMore Details
SAVE 12% today! Group A Streptococcal Infection- Market Insights, Epidemiology and Market Forecast 2028
Report Summary"Group A Streptococcal Infection- Market Insights, Epidemiology and Market Forecast 20...
26 Jul 2019 by MIReports USD $5,262 (normally
USD $5,980)
More Info
SAVE 12% today! Group B Streptococcal Infection- Market Insights, Epidemiology and Market Forecast 2028
Report Summary"Group B Streptococcal Infection- Market Insights, Epidemiology and Market Forecast 20...
26 Jul 2019 by MIReports USD $5,262 (normally
USD $5,980)
More Info
SAVE 12% today! 2019 Streptococcal Infections Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025
The global clinical trial report- “2019 Streptococcal Infections Clinical Trials Study” provides com...
24 Apr 2019 by VPA Research USD $1,583 (normally
USD $1,799)
More Info
SAVE 12% today! Streptococcal Infections Global Clinical Trials Review, H2, 2018
Streptococcal Infections Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial r...
31 Aug 2018 by Global Data USD $2,200 (normally
USD $2,500)
More Info
SAVE 12% today! Streptococcal Infections-API Insights, 2017
The active pharmaceutical ingredients worldwide market is in continuous development from the recent ...
30 May 2017 by Delve Insight USD $1,100 (normally
USD $1,250)
More Info
SAVE 12% today! Streptococcal Pneumonia - Pipeline Review, H2 2016
Streptococcal Pneumonia - Pipeline Review, H2 2016SummaryGlobal Markets Direct's latest Pharmaceutic...
21 Dec 2016 by Global Markets Direct USD $1,760 (normally
USD $2,000)
More Info
SAVE 12% today! Ampicillin Market Analysis: by Applications (Respiratory Tract Infection, Urinary Tract Infection, Meningitis, Salmonella Infections, Endocarditis, Others (Group 3 Streptococcal Infection, etc.)) Intake Method (by Mouth, by Injection into a Muscle, Intravenously) Target Bacteria Type (Gram Positive Bacteria, Gram Negative Bacteria)-Forecast(2016-2021)
Ampicillin, a semi-synthetic derivative of penicillin, causes cell death by interfering directly wit...
25 Jan 2016 by USD $4,620 (normally
USD $5,250)
More Info
SAVE 12% today! Streptococcal Infections Global Clinical Trials Review, H2, 2015
Streptococcal Infections Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinical trial r...
30 Dec 2015 by Global Data USD $2,200 (normally
USD $2,500)
More Info

This report is published by Delve Insight

DelveInsight is a leading Business Consulting and Market Research Firm. We combine industry expertise with probing market insights in innovative ways to deliver enduring results to deliver critical information to leading decision makers.

We help our clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. DelveInsight is a knowledge partner for business strategy and market research across the drug value chain.

We Stock...